Bio-Intervention Specialists Announces an Emergent Response Service for Facilities Experiencing a Spike in Hospital Acquir

Bio-Intervention Service Utilizes a Revolutionary, Newly Registered EPA Disinfectant that is Category IV practically non-toxic, environmentally friendly and offers a six log kill (99.9999%)

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Bio-Intervention Specialists (Bio-IS) announced today that beginning in late November, it will provide nationwide on-site bio-intervention services for hospitals experiencing infectious disease challenges. These services will be based on a recently EPA registered broad-spectrum hospital disinfectant, Electro-BioCide. Electro-BioCide is the first to market, EPA Category IV practically non-toxic, environmentally friendly disinfectant that also offers the broad spectrum, six log kill that healthcare institutions seek.

Bio-IS’ hospital disinfection service focuses on improving the overall disinfection of a hospital’s physical plant through an integrated “Bio-Intervention Process.” Combining the unique power of Electro-BioCide with a state-of-the-art electrostatic spraying system and certified bio-intervention personnel, Bio-IS is prepared to quickly respond on-site to any hospital in the United States. Bio-IS provides hospitals with a 21st Century technology solution to replace the spray bottle and rag that has been used for hard-surface disinfection for decades. Bio-Intervention specialist personnel can respond to emergent situations or can be positioned permanently at any hospital. The company’s bio-intervention service solves the current weak links of hard-surface infection control.

Bio-IS understands the significant challenge that hospital-acquired infections represent to healthcare providers. Accounting for nearly 100,000 deaths per year in the U.S. and infecting an estimated 1.7 million people, hospital-acquired infections are widely recognized as a patient safety and economic challenge that must be addressed. Business Week recently recognized “stopping infection in hospitals” as one of the top 5 methods for controlling healthcare costs.

Despite attempts to decrease the prevalence of hospital-acquired infections, research shows that the problem continues to grow. In April, the Associated Press quoted Nancy Foster, Vice President for Quality and Safety at the American Hospital Association, saying; “We are doing that which we know how to do, and it’s not having the intended effect. We need to identify other things we can do to drive down that rate of infections.”

Infection control experts have identified the hospital environment as an important reservoir for infectious organisms. Various studies have proven that hands become contaminated after touching environmental surfaces, yet current terminal clean protocols are often insufficient for stopping the spread of infection. For example, a 2008 study published in Infection Control and Epidemiology tested cleaning practices in 23 acute care hospitals. The study found that on average, less than half of the objects that were supposed to be disinfected during a terminal clean were actually addressed.

Electro-BioCide: A Highly Effective Disinfectant

Electro-BioCide is a revolutionary class of disinfectant with a unique kill mechanism. During third-party testing at the highly regarded ATS Labs in Eagan, MN, Electro-BioCide exhibited a 6-log kill (99.9999%) during EPA protocol testing against the following organisms:

  • MRSA
  • VRE
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Rhinovirus
  • Salmonella enterica
  • H1N1
  • HIV-1
  • Hepatitis A

An EPA approved, Environmentally Friendly, Practically Non-Toxic Disinfectant

In January 2009, Electro-BioCide underwent EPA-mandated live animal toxicity testing at Tox Monitor Labs in Chicago. Results from this testing confirmed that Electro-BioCide is a Category IV “practically non toxic” product. Category IV is the least toxic rating possible.

With every ingredient used to produce Electro-BioCide being DfE (Designed for Environment) certified, Electro-BioCide is a radical departure from the toxic, hazardous chemical disinfectants currently used in healthcare facilities.

To assure quality, Electro-BioCide is only sold as the key disinfectant in a service provided by certified bio-intervention specialists. It is not sold as a standalone product.

A Comprehensive Bio-Intervention:

Bio-IS does not replace the environmental services staff. Instead, Bio-IS works with hospital leadership, infection control committees and environmental services to implement a next-generation bio-intervention process. When new infection situations arise, Bio-IS can quickly attack such situations before they become worse.

“This is a new-to-the-world offering that can significantly improve the overall disinfection of a hospital’s environmental surfaces,” stated Tom Boyer, Chief Executive Officer, Bio-Intervention Specialists. “Our trained and certified teams deploy Electro-BioCide throughout patient care and other areas by using a state-of-art electronic spraying system. Our Bio-Intervention Service greatly minimizes the risk of human error and creates thorough coverage of hospital surfaces in a way that the spray bottle and rag simply cannot achieve. We accomplish a surgical style decontamination of hospital surfaces.”

Besides having its own personnel available to be permanently positioned at, or to travel to, hospitals with infectious disease issues, Bio-IS has partnered with HSS Inc., a highly regarded hospital services company that will also have personnel available to be permanently positioned at, or travel to, hospitals experiences infection challenges. HSS is rated by Modern Healthcare as one of the leading providers of healthcare support services in the country.

With EPA registration now complete, by late November Bio-Intervention Specialists will have the ability to respond to emergent situations for many states across the country as it completes required state registration processes. Registration in most states not approved by November is expected in December, with the exception of a small number of states that have longer registration cycles.

Bio-Intervention Services (Bio-IS) is dedicated to saving lives and reducing costs in the U.S. hospital system. Through an innovative Bio-Intervention process that comprehensively disinfects the physical plant of hospitals, Bio-IS will decrease the incidence and cost of hospital-acquired infections (HAIs).

Our EPA-registered product combined with our service protocol will help healthcare facilities confront the challenge of hospital-acquired infections by providing a cost effective and simple method for disinfecting environmental surfaces. For more information visit http://www.bio-intervention.com.

Bio-Intervention Specialists is a dba of Aion Partners LLC and is privately held, owned by its founders and employees, physicians, senior executives in the healthcare sector, and other private investors. The founder and CEO is Tom Boyer, with almost 20 years of experience in the healthcare sector. He served on the Board of HCA/HealthONE LLC (the largest hospital company in Colorado), as Chairman of the Colorado Health Foundation, and was founding Chairman of the Colorado Center for Nursing Excellence.



CONTACT:

Bio-Intervention Specialists
Media contact:
Lauri Harrison, 303-885-4200
[email protected]
or
Company contact:
Tom Boyer, 800-699-4230
Chief Executive Officer
[email protected]

KEYWORDS:   United States  North America  Colorado

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Infectious Diseases  Environment  Medical Supplies

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.